Wildman_2011_Chem.Biol.Drug.Des_78_495

Reference

Title : Drug-like leads for steric discrimination between substrate and inhibitors of human acetylcholinesterase - Wildman_2011_Chem.Biol.Drug.Des_78_495
Author(s) : Wildman SA , Zheng X , Sept D , Auletta JT , Rosenberry TL , Marshall GR
Ref : Chemical Biology Drug Des , 78 :495 , 2011
Abstract :

Protection of the enzyme acetylcholinesterase (AChE) from the toxic effects of organophosphate insecticides and chemical warfare agents (OPs) may be provided by inhibitors that bind at the peripheral binding site (P-site) near the mouth of the active-site gorge. Compounds that bind to this site may selectively block access to the acylation site (A-site) catalytic serine for OPs, but not acetylcholine itself. To identify such compounds, we employed a virtual screening approach using AutoDock 4.2 and AutoDock Vina, confirmed using compounds experimentally known to bind specifically to either the A-site or P-site. Both programs demonstrated the ability to correctly predict the binding site. Virtual screening of the NCI Diversity Set II was conducted using the apo form of the enzyme, and with acetylcholine bound at the crystallographic locations in the A-site only and in both and A- and P-sites. The docking identified 32 compounds that were obtained for testing, and one was demonstrated to bind specifically to the P-site in an inhibitor competition assay.

PubMedSearch : Wildman_2011_Chem.Biol.Drug.Des_78_495
PubMedID: 21668653

Related information

Citations formats

Wildman SA, Zheng X, Sept D, Auletta JT, Rosenberry TL, Marshall GR (2011)
Drug-like leads for steric discrimination between substrate and inhibitors of human acetylcholinesterase
Chemical Biology Drug Des 78 :495

Wildman SA, Zheng X, Sept D, Auletta JT, Rosenberry TL, Marshall GR (2011)
Chemical Biology Drug Des 78 :495